Brief: Autolus Therapeutics Selects Cardinal Health As U.S. Commercial Distribution Partner
27/04/2023 12:27
April 27 (Reuters) - Autolus Therapeutics PLC AUTL.O :
* AUTOLUS THERAPEUTICS SELECTS CARDINAL HEALTH AS U.S.
COMMERCIAL
DISTRIBUTION PARTNER
* AUTOLUS THERAPEUTICS PLC - CARDINAL HEALTH TO PROVIDE CORE
DISTRIBUTION CAPABILITIES REQUIRED FOR U.S. COMMERCIALIZATION OF
CAR T-CELL THERAPIES
* AUTOLUS THERAPEUTICS PLC - INNOVATIVE DEPOT MODEL INTENDED
TO
REDUCE DELIVERY TIME BY ALLOWING FOR TRANSIT WHILE PRODUCT
RELEASE IS FINALIZED
* AUTOLUS THERAPEUTICS PLC - CARDINAL HEALTH WILL HELP
PROVIDE
SEAMLESS ORDER-TO-CASH CAPABILITIES
Source text for Eikon: ID:nGNXm7dFQ
Further company coverage: AUTL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Autolus Therapeutics
See all newsBrief: Autolus Therapeutics PLC Unit Enters Master Service Agreement With AGC Biologics
Brief: Autolus Therapeutics Appoints Ryan Richardson To Board Of Directors
Brief: Nice Recommends Aucatzyl As A Treatment Option For Adult Patients With Lymphoblastic Leukemia
Brief: Autolus Therapeutics’ Car T Therapy Aucatzyl® (Obecabtagene Autoleucel) Granted European Marketing Authorization For Adult Patients
Brief: Autolus Therapeutics Announces Inducement Grants